NCT06884098View on ClinicalTrials.gov

A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284

PHASE1RecruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions

Primary Hypercholesterolaemia

Interventions

DRUG

AD-228B

AD-228B, 1Tab., Per Oral

DRUG

AD-2284

AD-2284, 1Tab., Per Oral

Trial Locations (1)

Unknown

RECRUITING

H Plus Yangji Hospital, Seoul

All Listed Sponsors

lead

Addpharma Inc.

INDUSTRY